Navigation Links
InterMune Reports Second Quarter 2014 Financial Results and Business Highlights
Date:8/6/2014

months of 2013, an increase of 165 percent. 

Research and development (R&D) expenses in the second quarter of 2014 were $39.7 million, compared with $27.5 million in the second quarter of 2013, an increase of 44 percent.  R&D expenses were $71.8 million for the six months ended June 30, 2014, compared with $53.4 million in the first six months of 2013, an increase of 34 percent.  Higher R&D expenses in both the three and six month periods reflect activities to complete and report the ASCEND Phase 3 trial, a higher number of patients in the RECAP extension study of pirfenidone compared to the year-earlier periods, and activities related to the preparation of the pirfenidone NDA resubmission.  R&D expenses in the second quarter of 2014 also reflect increased activity related to the company's product development activities, primarily the conduct of the LOTUSS, PANORAMA and PASSPORT (post-approval commitment safety and tolerability registry of 1,000 patients in Europe) studies, its several advancing anti-fibrotic research programs, and initiation and conduct of an Expanded Access Program (EAP) for pirfenidone in the United States.

Selling, general and administrative (SG&A) expenses were $52.6 million in the second quarter of 2014, compared with $37.3 million in the same period a year earlier, an increase of 41 percent.  SG&A expenses were $97.0 million in the first six months of 2014, an increase of 44 percent from $67.2 million in the same period of 2013.  The increased spending for the three and six month periods in 2014 compared with the same periods in 2013 is predominantly attributed to increasing investments in pre-launch preparations for pirfenidone in the United States.

InterMune reported a net loss for the second quarter of 2014 of $71.2 million, or $0.72 per share, compared with a net loss of $62.9 million, or $0.77 per share, in the second quarter of 2013.  Net loss for the fi
'/>"/>

SOURCE InterMune, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Reports Second Quarter 2013 Financial Results And Business Highlights
4. Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
5. InterMune Announces Presentations of New Research in IPF at ERS
6. InterMune Reports Second Quarter 2012 Financial Results and Business Highlights
7. InterMune to Divest Actimmune® (Interferon Gamma-1b)
8. Neurocrine Biosciences Reports Second Quarter 2014 Results
9. Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
10. China Biologic Reports Financial Results for the Second Quarter of 2014
11. Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... October 19, 2014 Große ... Das Problem dabei ist, dass große Pharmafirmen ... Kompetenz zu teilen. Es war deshalb ... wir uns umso mehr, dass es uns gelungen ... bei Kühlketten aufzuschreiben - mit einem Vorbehalt - ...
(Date:10/17/2014)... HILL, N.C. , Oct. 17, 2014 /PRNewswire/ ... insights is a critical success factor in today,s ... must develop market research organizations that effectively and ... location, specialty or service area. ... create value and earn recognition from internal clients ...
(Date:10/17/2014)... Oct. 17, 2014 UBM Medica US announces that ... online community and information resource for neurologists and other healthcare ... Alzheimer disease , with discussions of the latest developments ... million Americans have Parkinson disease , more than the total ... Lou Gehrig disease. Diagnosis can be difficult because there ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... March 19, 2012  BioStorage Technologies, a global provider ... cold chain logistics for the bioscience industry, announced ... webinar titled, "Comprehensive Sample Management: Leveraging an Onsite ... Thursday, March 22, from 11:00 AM to 12:30 ...
... Reportlinker.com announces that a new market research ... Branded Prescription Pharmaceutical Sales ... http://www.reportlinker.com/p0799256/Branded-Prescription-Pharmaceutical-Sales-Outlook-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ... achieved sales of $558bn having experienced a ...
Cached Medicine Technology:BioStorage Technologies to Host Live Webinar on Optimizing the Value of Sample Assets 2Branded Prescription Pharmaceutical Sales Outlook to 2016 2Branded Prescription Pharmaceutical Sales Outlook to 2016 3Branded Prescription Pharmaceutical Sales Outlook to 2016 4Branded Prescription Pharmaceutical Sales Outlook to 2016 5
(Date:10/20/2014)... With a mere 19 days to November 4, ... fundraising stop at the  Law Offices of Dan ... debate last night with his opponent Gov. Rick Scott, ... seven minutes because Crist had an electric fan underneath ... one word: "weird." , Before touching on his well-known ...
(Date:10/20/2014)... The Advocator Group, LLC is ... Foundation for Suicide Prevention’s (AFSP) Out of the Darkness ... organization that hosts hundreds of community walks throughout the ... used to help understand and prevent suicide through not ... well. , The Advocator Group shares this passion ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, Ob/Gyn ... Inc., A Division of MaternOhio Clinical Associates, Inc., who ... patients annually. Dr. Murphy will provide a full range ... women’s life. She is accepting new patients at two ... , Dr. Murphy offers a wide variety of services ...
(Date:10/20/2014)... hc1.com today announced the launch ... that enables healthcare organizations of all sizes to ... relationship management (“CRM”) solution. , Designed from the ... the healthcare industry, the hc1 Healthcare Relationship Cloud™ ... by combining healthcare CRM, HIPAA-compliant collaboration, and real-time ...
(Date:10/20/2014)... JZ Fitness, an independently operated wellness ... programming, authorship, international lecturing and community wellness, created by ... release of the JZ Fitness nutrition app, available on ... thousands of individuals on nutrition, Jenn Zerling (“JZ”) has ... require calorie counting or cumbersome food logging. ...
Breaking Medicine News(10 mins):Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3
... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... their health at home through the merger of rapid diagnostics ... quarter ended December 31, 2008.In the fourth quarter of 2008, ... net revenue of $288.0 million in the fourth quarter of ...
... Increase Transfusion IndependenceCROSSWICKS, N.J., Feb. 18 ... published in the peer reviewed medical journal The ... with higher-risk MDS. Myelodysplastic syndromes are a group of ... higher-risk patients have a median survival rate of less ...
... Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it ... an amended Phase 3 protocol for ATPace to be reviewed ... comments recently received from the FDA in response to the ... 2008.To address the FDA,s main comments, Cordex has changed the ...
... his son,s seemingly endless addiction to heroinFOUNTAIN VALLEY, Calif., ... other troubles we are born to know," ( published ... Neal had hoped never to write. Neal,s first book, ... heroin addiction and was written while Landon was in ...
... Service Study Shows Five Masimo Rad-57 Pulse CO-Oximeters(TM) Detected ... of the UK Reported Annual CO PoisoningsIRVINE, Calif., Feb. ... inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion ... report, the UK House of Commons All Party Parliamentary ...
... Calif., Feb. 18 A new wireless sensor ... required to build and,deploy wireless sensor nodes is ... module, designated as RS9110-N-11-31, is based on the ... benefits of,ultra low-power wireless connectivity and the network ...
Cached Medicine News:Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 2Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 3Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 4Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 5Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 6Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 7Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 8Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 9Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 10Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 11Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 12Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 13Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 14Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 15Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 16Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 17Health News:Inverness Medical Innovations Announces Fourth Quarter 2008 Results 18Health News:Video: The MDS Foundation Says Published Data Confirms VIDAZA(R) Significantly Extends Survival in Patients with the Malignant Condition MDS 2Health News:Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace 2Health News:Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace 3Health News:Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace 4Health News:Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace 5Health News:Author's Unwelcome Sequel Brings Light to Addiction 2Health News:Author's Unwelcome Sequel Brings Light to Addiction 3Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 2Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 3Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 4Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 5Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 6Health News:Redpine Signals Launches SenSiFi(TM), An Ultra Low-Power 802.11n (Wi-Fi(R)) Wireless Sensor Module 2Health News:Redpine Signals Launches SenSiFi(TM), An Ultra Low-Power 802.11n (Wi-Fi(R)) Wireless Sensor Module 3
... The LT-Cage device ... balance with significantly less ... endplates. Medtronic Sofamor Danek's ... designed to easily and ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int...
Designed for the effective positioning of patients during spinal surgery, the frame gives the surgeon a remarkably simple and versatile surgical tool....
Adjust-A-Tip cautery....
Medicine Products: